Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Visual Loss”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Testing effectiveness (Phase 2)Study completedNCT00066248
What this trial is testing

Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment

Who this might be right for
Brain TumorCentral Nervous System TumorsCachexia+5 more
University of South Florida 70
Post-approval studies (Phase 4)Ended earlyNCT00867815
What this trial is testing

PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Who this might be right for
Anterior Ischemic Optic Neuropathy
Bayer 10
Not applicableStudy completedNCT00873613
What this trial is testing

Digital Ocular Fundus Photography in the Emergency Department: A New Application for Telemedicine?

Who this might be right for
HeadacheAcute, Focal Neurologic DiseaseSeverely Elevated Blood Pressure+1 more
Emory University 705
Testing effectiveness (Phase 2)Looking for participantsNCT02521311
What this trial is testing

Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

Who this might be right for
Optic Neuritis
University of California, San Francisco 90
Testing effectiveness (Phase 2)Ended earlyNCT02737930
What this trial is testing

Fluoxetine for Visual Recovery After Ischemic Stroke

Who this might be right for
Acute StrokeVisual Field Loss
Bogachan Sahin 17
Not applicableStudy completedNCT06301815
What this trial is testing

Feasibility of Measuring Vertical Perception in Acute Stroke

Who this might be right for
Stroke
University of Winchester 53
Not applicableStudy completedNCT04792866
What this trial is testing

3D FLAIR Versus Coronal T2-WI MRI in Detecting Optic Neuritis (FLACON)

Who this might be right for
Optic NeuritisMultiple SclerosisEncephalopathy
Fondation Ophtalmologique Adolphe de Rothschild 1,200
Not applicableStudy completedNCT04793087
What this trial is testing

Post-COntrast 3D SE T1 Versus Coronal SE T1-WI MRI in Detecting Optic Neuritis (COCON)

Who this might be right for
Optic NeuritisMultiple Sclerosis
Fondation Ophtalmologique Adolphe de Rothschild 1,200